Hell D - Search Results

1

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

Liechti ME, Geyer MA, Hell D, Vollenweider FX. Liechti ME, et al. Among authors: hell d. Neuropsychopharmacology. 2001 Mar;24(3):240-52. doi: 10.1016/S0893-133X(00)00199-8. Neuropsychopharmacology. 2001. PMID: 11166515

2

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET).

Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J. Vollenweider FX, et al. Among authors: hell d. Eur Neuropsychopharmacol. 1997 Feb;7(1):25-38. doi: 10.1016/s0924-977x(96)00042-9. Eur Neuropsychopharmacol. 1997. PMID: 9088882 Clinical Trial.

3

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

Vollenweider FX, Vontobel P, Hell D, Leenders KL. Vollenweider FX, et al. Among authors: hell d. Neuropsychopharmacology. 1999 May;20(5):424-33. doi: 10.1016/S0893-133X(98)00108-0. Neuropsychopharmacology. 1999. PMID: 10192823 Clinical Trial.

4

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.

Vollenweider FX, Remensberger S, Hell D, Geyer MA. Vollenweider FX, et al. Among authors: hell d. Psychopharmacology (Berl). 1999 Apr;143(4):365-72. doi: 10.1007/s002130050960. Psychopharmacology (Berl). 1999. PMID: 10367553 Clinical Trial.

5

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX. Liechti ME, et al. Among authors: hell d. Neuropsychopharmacology. 2000 Oct;23(4):396-404. doi: 10.1016/S0893-133X(00)00126-3. Neuropsychopharmacology. 2000. PMID: 10989266 Clinical Trial.

6

Prepulse inhibition deficits in patients with panic disorder.

Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX. Ludewig S, et al. Among authors: hell d. Depress Anxiety. 2002;15(2):55-60. doi: 10.1002/da.10026. Depress Anxiety. 2002. PMID: 11891993

7

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.

Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Vollenweider FX, et al. Among authors: hell d. Neuroreport. 1998 Dec 1;9(17):3897-902. doi: 10.1097/00001756-199812010-00024. Neuroreport. 1998. PMID: 9875725 Clinical Trial.

8

Mood state and brain electric activity in ecstasy users.

Gamma A, Frei E, Lehmann D, Pascual-Marqui RD, Hell D, Vollenweider FX. Gamma A, et al. Among authors: hell d. Neuroreport. 2000 Jan 17;11(1):157-62. doi: 10.1097/00001756-200001170-00031. Neuroreport. 2000. PMID: 10683849 Clinical Trial.

9

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL. Vollenweider FX, et al. Among authors: hell d. J Psychiatr Res. 2000 Jan-Feb;34(1):35-43. doi: 10.1016/s0022-3956(99)00031-x. J Psychiatr Res. 2000. PMID: 10696831 Clinical Trial.

10

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Umbricht D, et al. Among authors: hell d. Arch Gen Psychiatry. 2000 Dec;57(12):1139-47. doi: 10.1001/archpsyc.57.12.1139. Arch Gen Psychiatry. 2000. PMID: 11115327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters